BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 10389533)

  • 1. [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
    Wolffenbuttel BH; Heine RJ
    Ned Tijdschr Geneeskd; 1999 Jun; 143(23):1197-201. PubMed ID: 10389533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the United Kingdom prospective diabetes study.
    Baldeweg SE; Yudkin JS
    Prim Care; 1999 Dec; 26(4):809-27. PubMed ID: 10523461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycaemic and blood pressure controls achieved in a cohort of 318 patients with type 2 diabetes.
    Buysschaert M; Hermans MP
    Acta Clin Belg; 1999 Dec; 54(6):328-33. PubMed ID: 10686705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of type 2 diabetes: good news from the UK.
    Smith RB; Mann JI
    N Z Med J; 1999 May; 112(1087):149-50. PubMed ID: 10378808
    [No Abstract]   [Full Text] [Related]  

  • 5. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):703-13. PubMed ID: 9732337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
    UK Prospective Diabetes Study Group
    BMJ; 1998 Sep; 317(7160):713-20. PubMed ID: 9732338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fasting blood glucose, diabetes treatment, blood pressure and anti-hypertension treatment on cardiovascular disease incidence: a 30-year follow-up study of 740 incident patients with Type 2 diabetes.
    Jansson SP; Andersson DK; Svärdsudd K
    Diabet Med; 2013 Mar; 30(3):349-57. PubMed ID: 23278364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
    Diabetes; 1995 Nov; 44(11):1249-58. PubMed ID: 7589820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
    CDC Diabetes Cost-effectiveness Group
    JAMA; 2002 May; 287(19):2542-51. PubMed ID: 12020335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
    Wolffenbuttel BH; van Haeften TW
    Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of obesity hypertension and diabetes syndrome.
    Zanella MT; Kohlmann O; Ribeiro AB
    Hypertension; 2001 Sep; 38(3 Pt 2):705-8. PubMed ID: 11566961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of diabetic patients with cardiovascular complications.
    Sawicki PT; Berger M
    J Intern Med; 1998 Mar; 243(3):181-9. PubMed ID: 9627154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antihypertensive therapy in decreasing renal and cardiovascular complications in diabetes mellitus.
    Nosadini R; Abaterusso C; Dalla Vestra M; Bortoloso E; Saller A; Bruseghin M; Sfriso A; Trevisan M
    Nephrol Dial Transplant; 1998; 13 Suppl 8():44-8. PubMed ID: 9870425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.
    Zarich SW
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S19-28. PubMed ID: 14668700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hypertension associated with diabetes mellitus].
    Katayama S
    Nihon Rinsho; 1997 Aug; 55(8):2091-6. PubMed ID: 9284429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta blockers and diuretics: therapeutic drugs of first choice in diabetes mellitus and hypertension].
    Sawicki PT
    Wien Klin Wochenschr; 1995; 107(21):629-39. PubMed ID: 8578749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension and diabetes].
    Bouhanick B; Laboureau-Soares Barbosa S; Marre M
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1429-34. PubMed ID: 11190292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing the diabetic hypertensive patient.
    Poulter NR
    J Diabetes Complications; 1996; 10(3):141-3. PubMed ID: 8807460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.
    Anan F; Masaki T; Fukunaga N; Teshima Y; Iwao T; Kaneda K; Umeno Y; Okada K; Wakasugi K; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
    Eur J Clin Invest; 2007 Sep; 37(9):709-14. PubMed ID: 17696960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.